Active ingredient
Tremelimumab NDC Codes
Tremelimumab is an active ingredient in 2 finished products listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Imjudo
- Labelers
- AstraZeneca Pharmaceuticals LP
- Strengths
- Tremelimumab 300 mg/15mL; Tremelimumab 25 mg/1.25mL
- Dosage forms
- Injection, Solution
- Routes
- Intravenous
- Drug classes (FDA established)
- CTLA-4-directed Blocking Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 2
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Imjudotremelimumab | Tremelimumab 300 mg/15mL | Injection, SolutionIntravenous | AstraZeneca Pharmaceuticals LP | 0310-4535 | 00310-4535-30 | — |
| Imjudotremelimumab | Tremelimumab 25 mg/1.25mL | Injection, SolutionIntravenous | AstraZeneca Pharmaceuticals LP | 0310-4505 | 00310-4505-25 | — |
Tremelimumab: common questions
- Which drugs contain Tremelimumab?
- Imjudo.
- Is there a J-code for Tremelimumab?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.